RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Kindred Biosciences - Stock

Kindred Biosciences EBIT 2024

Kindred Biosciences EBIT

0 USD

Ticker

KIN

ISIN

US4945771099

WKN

A1XA6K

In 2024, Kindred Biosciences's EBIT was 0 USD, a 0% increase from the 0 USD EBIT recorded in the previous year.

The Kindred Biosciences EBIT history

YEAREBIT (undefined USD)
2024e-
2023e-
2022e-
2021e-
2020-
2019-
2018-
2017-
2016-
2015-
2014-
2013-
2012-

Kindred Biosciences Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Kindred Biosciences, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Kindred Biosciences from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Kindred Biosciences’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Kindred Biosciences. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Kindred Biosciences’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Kindred Biosciences’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Kindred Biosciences’s growth potential.

Kindred Biosciences Revenue, EBIT and net profit per share

DateKindred Biosciences RevenueKindred Biosciences EBITKindred Biosciences Net Income
2024e21.8 M undefined0 undefined0 undefined
2023e23.54 M undefined0 undefined0 undefined
2022e25.94 M undefined0 undefined-45.46 M undefined
2021e18.08 M undefined0 undefined-45.46 M undefined
202042.16 M undefined-11.9 M undefined-21.8 M undefined
20194.26 M undefined-62.57 M undefined-61.39 M undefined
20181.97 M undefined-51.26 M undefined-49.69 M undefined
20170 undefined-31.65 M undefined-30.88 M undefined
20160 undefined-22.16 M undefined-22.5 M undefined
20150 undefined-27.26 M undefined-27.13 M undefined
20140 undefined-27.23 M undefined-27.14 M undefined
20130 undefined-4.22 M undefined-4.21 M undefined
20120 undefined-120,000 undefined-120,000 undefined

Kindred Biosciences stock margins

The Kindred Biosciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Kindred Biosciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Kindred Biosciences.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Kindred Biosciences's sales revenue. A higher gross margin percentage indicates that the Kindred Biosciences retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Kindred Biosciences's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Kindred Biosciences's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Kindred Biosciences's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Kindred Biosciences. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Kindred Biosciences's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Kindred Biosciences Margin History

Kindred Biosciences Gross marginKindred Biosciences Profit marginKindred Biosciences EBIT marginKindred Biosciences Profit margin
2024e98.1 %0 %0 %
2023e98.1 %0 %0 %
2022e98.1 %0 %-175.23 %
2021e98.1 %0 %-251.39 %
202098.1 %-28.23 %-51.71 %
201986.15 %-1,468.78 %-1,441.08 %
201883.25 %-2,602.03 %-2,522.33 %
201798.1 %0 %0 %
201698.1 %0 %0 %
201598.1 %0 %0 %
201498.1 %0 %0 %
201398.1 %0 %0 %
201298.1 %0 %0 %

Kindred Biosciences Aktienanalyse

What does Kindred Biosciences do?

Kindred Biosciences Inc. is a biopharmaceutical company that was founded in 2012 by Richard Chin, an experienced pharmaceutical entrepreneur. The company's goal is to develop and bring to market innovative animal medicines for pets. The business model of Kindred Biosciences is based on the identification and development of novel, safe, and effective animal medicines for dogs, cats, and horses. The company utilizes state-of-the-art technologies and research methods to develop high-quality products that meet the needs of veterinarians and pet owners. The company currently has three main business segments: biologics, biopharmaceuticals, and small molecules. Each of these segments focuses on specific animal diseases and offers a unique range of products. The biologics segment of Kindred Biosciences develops innovative vaccines for dogs and cats that are highly effective and have improved tolerability. Kindred Biosciences' vaccines are specifically tailored to the needs of pets and can help prevent infections and diseases in dogs and cats. The biopharmaceuticals segment of Kindred Biosciences develops novel therapies for chronic diseases in dogs and cats, such as chronic pain, inflammation, and cancer. The company utilizes state-of-the-art technologies and research methods to develop effective and safe therapies that meet the needs of veterinarians and pet owners. The small molecules segment of Kindred Biosciences develops novel drugs for horses that are highly effective and have improved tolerability. Kindred Biosciences' drugs are specifically tailored to the needs of horses and can help treat various conditions such as arthritis or colic. The company has a broad range of products, currently consisting of over a dozen products that focus on different animal species, diseases, and needs. These include therapies for chronic pain, inhalation anesthetics, drugs for cancer and inflammation, as well as vaccines for various infections. Kindred Biosciences has achieved significant success in recent years. The company has conducted numerous clinical trials and brought several drugs and vaccines to market. In 2018, the company received approval from the Food and Drug Administration (FDA) for a groundbreaking therapy for chronic pain in dogs. The company also has a strong pipeline of products in development that could contribute to supporting the company's growth in the coming years. In summary, Kindred Biosciences is an innovative biopharmaceutical company focused on the development and commercialization of innovative animal medicines. The company has a broad range of products and is capable of developing high-quality products for a variety of animal species, diseases, and needs. With a strong pipeline and a successful track record, Kindred Biosciences is well-positioned to solidify its leading position in the industry and accelerate its growth in the coming years. Kindred Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Kindred Biosciences's EBIT

Kindred Biosciences's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Kindred Biosciences's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Kindred Biosciences's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Kindred Biosciences’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Kindred Biosciences Stock

How much did Kindred Biosciences achieve in EBIT for the current year?

In the current year, Kindred Biosciences has achieved an EBIT of 0 USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Kindred Biosciences.

How has the EBIT of Kindred Biosciences developed in recent years?

The EBIT of Kindred Biosciences has increased by 0% decreased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Kindred Biosciences?

The EBIT of Kindred Biosciences is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Kindred Biosciences pay?

Over the past 12 months, Kindred Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Kindred Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Kindred Biosciences?

The current dividend yield of Kindred Biosciences is .

When does Kindred Biosciences pay dividends?

Kindred Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Kindred Biosciences?

Kindred Biosciences paid dividends every year for the past 0 years.

What is the dividend of Kindred Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Kindred Biosciences located?

Kindred Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kindred Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kindred Biosciences from 7/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/2/2024.

When did Kindred Biosciences pay the last dividend?

The last dividend was paid out on 7/2/2024.

What was the dividend of Kindred Biosciences in the year 2023?

In the year 2023, Kindred Biosciences distributed 0 USD as dividends.

In which currency does Kindred Biosciences pay out the dividend?

The dividends of Kindred Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Kindred Biosciences stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Kindred Biosciences

Our stock analysis for Kindred Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kindred Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.